In order to bring you the best possible user experience, this site uses Javascript. If you are seeing this message, it is likely that the Javascript option in your browser is disabled. For optimal viewing of this site, please ensure that Javascript is enabled for your browser.
Did you know that your browser is out of date? To get the best experience using our website we recommend that you upgrade to a newer version. Learn more.

Symposium: single cell analysis in Atherosclerosis

ESC Working Group on Atherosclerosis and Vascular Biology

23/04/2020 14:00 23/04/2020 16:00 Europe/Paris Symposium: single cell analysis in Atherosclerosis

The application of the rapidly evolving field of single-cell technologies like CyTOF and single-cell RNAseq is allowing identification of novel cell communities that are important in CVD. Based on recent and many ongoing studies we will be able to improve patient-at-risk identification and define new therapeutic strategies for treatment of disease.

Join the discussion during the 4th biennial Symposium of the ESC Working Group on Atherosclerosis and Vascular Biology organised just before the Frontiers in CardioVascular Biomedicine (FCVB) Congress.

ESC Working Group on Atherosclerosis & Vascular Biology contact@escardio.org DD/MM/YYYY
Atherosclerosis, Cerebrovascular Diseases, Aneurysm, Restenosis
Basic Science
Vascular Biology and Physiology
In-person
event

Summary

The application of the rapidly evolving field of single-cell technologies like CyTOF and single-cell RNAseq is allowing identification of novel cell communities that are important in CVD. Based on recent and many ongoing studies we will be able to improve patient-at-risk identification and define new therapeutic strategies for treatment of disease.

Join the discussion during the 4th biennial Symposium of the ESC Working Group on Atherosclerosis and Vascular Biology organised just before the Frontiers in CardioVascular Biomedicine (FCVB) Congress.



Learning objectives

  • Understand recent technical developments in this rapidly evolving field
  • Understand recent advances in defining immune cell function in CVD based on single-cell technologies
  • Understand linking these new insights to patients (new diagnostics and risk factors for patient stratification, new therapeutics)

Preliminary Programme

Chairpersons:

  1. Marie-Luce Bochaton-Piallat (University of Geneva, Switserland)
  2. Menno de Winther (Amsterdam UMC, The Netherlands)

Speakers:

  1. Helle Jorgensen (University of Cambridge, UK)
  2. Claudia Monaco (Oxford University, UK)
  3. Michael Simons (Yale University School of Medicine, USA)
  4. Holger Winkels (La Jolla Institute for Immunology, USA)
  5. Seppo Ylä-Herttuala (University of Eastern Finland, Finland)

Sessions:

  • Introduction - Magnus Back (ESC WG AtVB chairperson)
  • Single cell dynamics of atherosclerotic lesions - Michael Simons
  • Immune cells in atherosclerosis: one cell at a time - Claudia Monaco
  • Single cell analyses of murine atherosclerosis to better understand human disease - Seppo Ylä-Herttuala
  • Single cell analysis of atherosclerosis-relevant CD4 T cells - Holger Winkels
  • Smooth muscle cell heterogeneity in vascular disease - Helle Jorgensen

Free registration

Being a Member of the Working Group on Atherosclerosis & Vascular Biology is a pre-requisite to participate in the Symposium.

Join the Working Group

Membership is free.

When your membership application is completed, you will be able to register.

Register

Venue

Semmelweis University, Basic Medical Center, Üllői út 26, Budapest, Hungary

First floor, room Beznak